diglycyl-histidine has been researched along with Leukemia P388 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernier, JL; Boitte, N; Catteau, JP; Duvalet, JL; Fournier, C; Hecquet, B; Helbecque, N; Hénichart, JP; Morier-Teissier, E; Pommery, N | 1 |
1 other study(ies) available for diglycyl-histidine and Leukemia P388
| Article | Year |
|---|---|
Synthesis and antitumor properties of an anthraquinone bisubstituted by the copper chelating peptide Gly-Gly-L-His.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Chelating Agents; Free Radicals; Leukemia L1210; Leukemia P388; Mice; Oligopeptides; Structure-Activity Relationship | 1993 |